Literature DB >> 20694581

The proliferation and differentiation of stem cell journals.

Paul R Sanberg1, Cesar V Borlongan.   

Abstract

As scientists position themselves in translating the therapeutic potential of stem cells from laboratory to clinical applications, publishing companies have taken this rapidly evolving field as a unique opportunity to launch new journals for dissemination of stem cell research. Over the last decade, the significant increase in the number of stem cell-based journals has created a conundrum. At stake is the pressure for these new journals to build their reputation by maintaining publication standards, while at the same time attracting a cadre of stem cell researchers to consider their journals as the publication of choice. We discuss here a prophetic path of survival for these journals which likely will closely mimic the core scientific and translational value of stem cells, namely their capacity to proliferate and differentiate into something meaningful!

Mesh:

Year:  2010        PMID: 20694581     DOI: 10.1007/s12015-010-9181-y

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  5 in total

Review 1.  Promising new sources for pluripotent stem cells.

Authors:  Christian Leeb; Marcin Jurga; Colin McGuckin; Richard Moriggl; Lukas Kenner
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

2.  Isolation, characterization, and differentiation potential of canine adipose-derived stem cells.

Authors:  N M Vieira; V Brandalise; E Zucconi; M Secco; B E Strauss; M Zatz
Journal:  Cell Transplant       Date:  2009-12-08       Impact factor: 4.064

Review 3.  Stem cell transplants at childbirth.

Authors:  Paul R Sanberg; Dong-Hyuk Park; Cesar V Borlongan
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

Review 4.  The promise of stem cell research in pigs and other ungulate species.

Authors:  Bhanu Prakash V L Telugu; Toshihiko Ezashi; R Michael Roberts
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

5.  Use of lectins to enrich mouse ES-derived retinal progenitor cells for the purpose of transplantation therapy.

Authors:  Michiko Mandai; Hanako Ikeda; Zi-Bing Jin; Kyoko Iseki; Chie Ishigami; Masayo Takahashi
Journal:  Cell Transplant       Date:  2009-10-09       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.